
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine
(Reuters) – Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk product and the final freeze-dried doses of its mpox and smallpox vaccine, Jynneos, it said on Tuesday. As per the contract, the Danish biotech company will manufacture 1 million freeze-dried vaccines to be delivered by 2026,…